Journal article icon

Journal article

Tumour vascular disrupting agents: combating treatment resistance.

Abstract:

A large group of tubulin-binding microtubule-depolymerizing agents act as tumour vascular disrupting agents (VDAs). Several members of this group are now in clinical trials in combination with conventional anticancer drugs and radiotherapy. Here we briefly update on the development of tubulin-binding combretastatins as VDAs, summarize what is known of their mechanisms of action and address issues relating to treatment resistance, using disodium combretastatin A-4 3-O-phosphate (CA-4-P) as an ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1259/bjr/36205483

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
Journal:
British journal of radiology More from this journal
Volume:
81 Spec No 1
Issue:
SPECIAL ISSUE
Pages:
S12-S20
Publication date:
2008-10-01
DOI:
EISSN:
1748-880X
ISSN:
0007-1285
Language:
English
Keywords:
Pubs id:
pubs:130974
UUID:
uuid:2168bd06-f5dc-443a-865f-18863d712842
Local pid:
pubs:130974
Source identifiers:
130974
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP